452 related articles for article (PubMed ID: 31623983)
1. Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study.
Rajabi F; Rohr F; Wessel A; Martell L; Dobrowolski SF; Guldberg P; Güttler F; Levy HL
Mol Genet Metab; 2019 Dec; 128(4):415-421. PubMed ID: 31623983
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanine hydroxylase deficiency in the Slovak population: genotype-phenotype correlations and genotype-based predictions of BH4-responsiveness.
Polak E; Ficek A; Radvanszky J; Soltysova A; Urge O; Cmelova E; Kantarska D; Kadasi L
Gene; 2013 Sep; 526(2):347-55. PubMed ID: 23764561
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China.
Zhang Z; Gao JJ; Feng Y; Zhu LL; Yan H; Shi XF; Chang AM; Shi Y; Wang P
Scand J Clin Lab Invest; 2018 May; 78(3):211-218. PubMed ID: 29390883
[TBL] [Abstract][Full Text] [Related]
4. The Genetic Landscape and Epidemiology of Phenylketonuria.
Hillert A; Anikster Y; Belanger-Quintana A; Burlina A; Burton BK; Carducci C; Chiesa AE; Christodoulou J; Đorđević M; Desviat LR; Eliyahu A; Evers RAF; Fajkusova L; Feillet F; Bonfim-Freitas PE; Giżewska M; Gundorova P; Karall D; Kneller K; Kutsev SI; Leuzzi V; Levy HL; Lichter-Konecki U; Muntau AC; Namour F; Oltarzewski M; Paras A; Perez B; Polak E; Polyakov AV; Porta F; Rohrbach M; Scholl-Bürgi S; Spécola N; Stojiljković M; Shen N; Santana-da Silva LC; Skouma A; van Spronsen F; Stoppioni V; Thöny B; Trefz FK; Vockley J; Yu Y; Zschocke J; Hoffmann GF; Garbade SF; Blau N
Am J Hum Genet; 2020 Aug; 107(2):234-250. PubMed ID: 32668217
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation.
Shen N; Heintz C; Thiel C; Okun JG; Hoffmann GF; Blau N
Mol Genet Metab; 2016 Mar; 117(3):328-35. PubMed ID: 26803807
[TBL] [Abstract][Full Text] [Related]
6. START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients.
Utz JR; Lorentz CP; Markowitz D; Rudser KD; Diethelm-Okita B; Erickson D; Whitley CB
Mol Genet Metab; 2012 Feb; 105(2):193-7. PubMed ID: 22112818
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlations and BH
Vieira Neto E; Laranjeira F; Quelhas D; Ribeiro I; Seabra A; Mineiro N; Carvalho LM; Lacerda L; Ribeiro MG
Mol Genet Genomic Med; 2019 May; 7(5):e610. PubMed ID: 30829006
[TBL] [Abstract][Full Text] [Related]
8. Phenylalanine hydroxylase deficiency in Mexico: genotype-phenotype correlations, BH4 responsiveness and evidence of a founder effect.
Vela-Amieva M; Abreu-González M; González-del Angel A; Ibarra-González I; Fernández-Lainez C; Barrientos-Ríos R; Monroy-Santoyo S; Guillén-López S; Alcántara-Ortigoza MA
Clin Genet; 2015 Jul; 88(1):62-7. PubMed ID: 24941924
[TBL] [Abstract][Full Text] [Related]
9. Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population.
Zhu T; Ye J; Han L; Qiu W; Zhang H; Liang L; Gu X
Gene; 2013 Oct; 529(1):80-7. PubMed ID: 23932990
[TBL] [Abstract][Full Text] [Related]
10. Phenylalanine hydroxylase deficiency in south Italy: Genotype-phenotype correlations, identification of a novel mutant PAH allele and prediction of BH4 responsiveness.
Trunzo R; Santacroce R; D'Andrea G; Longo V; De Girolamo G; Dimatteo C; Leccese A; Bafunno V; Lillo V; Papadia F; Margaglione M
Clin Chim Acta; 2015 Oct; 450():51-5. PubMed ID: 26210745
[TBL] [Abstract][Full Text] [Related]
11. An Updated
Vela-Amieva M; Alcántara-Ortigoza MA; Ibarra-González I; González-Del Angel A; Fernández-Hernández L; Guillén-López S; López-Mejía L; Carrillo-Nieto RI; Belmont-Martínez L; Fernández-Lainez C
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828281
[TBL] [Abstract][Full Text] [Related]
12. Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency.
Karacić I; Meili D; Sarnavka V; Heintz C; Thöny B; Ramadza DP; Fumić K; Mardesić D; Barić I; Blau N
Mol Genet Metab; 2009 Jul; 97(3):165-71. PubMed ID: 19394257
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of phenylketonuria in Jiangsu province.
Chen YF; Jia HT; Chen ZH; Song JP; Liang Y; Pei JJ; Wu ZJ; Wang J; Qiu YL; Liu G; Sun DM; Jiang XY
Eur J Pediatr; 2015 Oct; 174(10):1333-8. PubMed ID: 25894915
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Türkiye.
Alavanda C; Ceylan Eİ; Kılavuz S; Çıkı K
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):543-552. PubMed ID: 38706300
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria.
Aldámiz-Echevarría L; Llarena M; Bueno MA; Dalmau J; Vitoria I; Fernández-Marmiesse A; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; Peña-Quintana L; González D; Sánchez-Valverde F; Desviat LR; Pérez B; Couce ML
J Hum Genet; 2016 Aug; 61(8):731-44. PubMed ID: 27121329
[TBL] [Abstract][Full Text] [Related]
17. Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia.
Gramer G; Burgard P; Garbade SF; Lindner M
J Inherit Metab Dis; 2007 Aug; 30(4):556-62. PubMed ID: 17680344
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness.
Jeannesson-Thivisol E; Feillet F; Chéry C; Perrin P; Battaglia-Hsu SF; Herbeth B; Cano A; Barth M; Fouilhoux A; Mention K; Labarthe F; Arnoux JB; Maillot F; Lenaerts C; Dumesnil C; Wagner K; Terral D; Broué P; de Parscau L; Gay C; Kuster A; Bédu A; Besson G; Lamireau D; Odent S; Masurel A; Guéant JL; Namour F
Orphanet J Rare Dis; 2015 Dec; 10():158. PubMed ID: 26666653
[TBL] [Abstract][Full Text] [Related]
19. Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene.
Groselj U; Tansek MZ; Kovac J; Hovnik T; Podkrajsek KT; Battelino T
Mol Genet Metab; 2012 Jun; 106(2):142-8. PubMed ID: 22513348
[TBL] [Abstract][Full Text] [Related]
20. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.
Erlandsen H; Stevens RC
J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
